Wells Fargo Maintains Autolus Therapeutics(AUTL.US) With Buy Rating, Maintains Target Price $8

Futu NewsJan 14 18:33 · Ratings

Positive Buy Rating for Autolus Therapeutics Driven by Aucatzyl's Promising Launch and Strategic Growth Prospects

TipRanksJan 14 17:58 · Ratings

Autolus Reports FDA Approval and NCCN Inclusion of AUCATZYL, Sets Milestones for Pipeline Growth

BenzingaJan 13 21:25

Press Release: Autolus Therapeutics Provides Business Updates and 2025 Overview

Dow JonesJan 13 20:00

Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now?

Yahoo FinanceDec 31, 2024 03:43

European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading

MT NewswiresDec 12, 2024 00:33